Biomedical subjects
Svein Reseland
Publications and source records attributed to Svein Reseland.
Relationship between antidepressant sales and secular trends in suicide rates in the Nordic countries.
BACKGROUND: The effect of recent increases in antidepressant prescribing on population suicide rates is uncertain. AIMS: To investigate the relationship between antidepressant sales and trends in suicide rates. METHOD: Graphical and quantitative assessment of trends in suicide and antidepressant sales in Norway, Sweden, Denmark and Finland. RESULTS: Suicide rates declined in all four countries during the 1990 s, whereas antidepressant sales increased by 3- to 4-fold. Decreasing suicide rates in Sweden and Denmark preceded the rise in antidepressant sales by over 10 years, although the reductions accelerated between 1988 and 1990. In Norway, a modest but short-lived decline in suicide rates began around the time of the increase in antidepressant sales. In Finland, decreases in male suicide rates and to a lesser extent in female suicide rates began around the time of increased antidepressant sales. In all four countries decreases in suicide rates appeared to precede the widespread use of SSRIs. CONCLUSIONS: We found mixed evidence that increases in antidepressant sales have coincided with a reduction in the number of suicides in Nordic countries.
[Fatal drug adverse effects].
Explore the source record for details and available documents.
[A group of physicians battling against?].
Explore the source record for details and available documents.
[Adverse effects--making nail soup or nailing the coffin?].
Explore the source record for details and available documents.
[Is current prescription practice of SSRI justifiable?].
Explore the source record for details and available documents.
[Discouraging about drug therapy?].
Explore the source record for details and available documents.
[Selective serotonin reuptake inhibitors--adverse effects not documented?].
Explore the source record for details and available documents.
[Selective serotonin reuptake inhibitors--damages not documented?].
Explore the source record for details and available documents.